NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / NYLI US LC R&D L
Number of holders
3
Total 13F shares, excl. options
199K
Shares change
+913
Total reported value, excl. options
$6.62M
Value change
+$30.4K
Number of buys
2
Price
$33.30

Significant Holders of NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) as of Q3 2024

3 filings reported holding LRND - NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L as of Q3 2024.
NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 199K shares .
Largest 3 shareholders include NEW YORK LIFE INVESTMENT MANAGEMENT LLC (190K shares), GTS SECURITIES LLC (8.87K shares), and ASSETMARK, INC (66 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.